We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
- Authors
Gill, Sharlene; Loprinzi, Charles L; Sargent, Daniel J; Thomé, Stephan D; Alberts, Steven R; Haller, Daniel G; Benedetti, Jacqueline; Francini, Guido; Shepherd, Lois E; Francois Seitz, Jean; Labianca, Roberto; Chen, Wei; Cha, Stephen S; Heldebrant, Michael P; Goldberg, Richard M
- Abstract
Although it is well-established that fluorouracil- (FU-) based adjuvant therapy improves survival for patients with resected high-risk colon cancer, the magnitude of adjuvant therapy benefit across specific subgroups and for individual patients has been uncertain.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Vol 22, Issue 10, p1797
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2004.09.059